Since the DNA repair enzyme poly(ADP-ribose) polymerase (PARP) is expressed at higher levels in tumor cells when compared to benign tissues and cells [2], [3], PARP may therefore represent a tumor specific treatment target. Here, PARP1 is linked to neoplasm.